Therapy News and Research

RSS

Treatment with luspatercept improves red blood cell counts in patients with myelodysplastic syndromes

Treatment with luspatercept improved red blood cell counts and erythroid responses compared to treatment with epoetin alfa in patients with myelodysplastic syndromes (MDS), allowing the majority to no longer require regular blood transfusions.

26 May 2023

Addressing sexual health issues of breast cancer patients on endocrine therapy

Breast cancer treatments that can save a woman's life can seriously harm her sexual health, says Dr. Kristin E. Rojas, a breast cancer surgeon at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine.

26 May 2023

Recent evolution of the LAAO therapy for thromboembolic complications

Announcing a new article publication for Cardiovascular Innovations and Applications journal.

26 May 2023

Fibromyalgia causes structural brain changes

Pain-processing regions are particularly affected by changes in brain volume. The good news is that these changes may be reversible.

26 May 2023

The potential clinical benefit of the Multabody platform as a therapeutic for SARS-CoV-2

The potential clinical benefit of the Multabody platform as a therapeutic for SARS-CoV-2.

26 May 2023

Nonhuman primate study helps explain how stem cell transplantation can kill HIV virus

New animal research is helping explain why at least five people have become HIV-free after receiving a stem cell transplant.

25 May 2023

UTHealth Houston receives federal funding for traumatic brain injury research

Nearly $13 million in federal grant funds to study treatments for traumatic brain injury, which kills an average of 190 people and hospitalizes another 600 in the U.S. every day, has been awarded to UTHealth Houston by the Department of Defense's Office of Congressionally Directed Medical Research Programs (CDMRP).

25 May 2023

Case study: Experimental lecanemab treatment causes adverse outcomes in 65-year-old woman with Alzheimer's disease

In a noteworthy case study published in the Journal of Alzheimer's Disease investigators report autopsy findings in a 65-year-old woman with Alzheimer's disease (AD) who received three open label infusions of the experimental anti-amyloid beta (Aβ) antibody drug lecanemab.

25 May 2023

Manipulating a signaling protein to slow down muscular dystrophy

A team of researchers at the University of Houston College of Pharmacy is reporting that by manipulating TAK1, a signaling protein that plays an important role in development of the immune system, they can slow down disease progression and improve muscle function in Duchenne muscular dystrophy (DMD).

25 May 2023

A trans teen no longer feels welcome in Florida. So she left.

Josie had put off packing long enough. The high school sophomore in St. Augustine, Florida, sat on her bed while her mom, Sarah, pulled clothes from her closet.

25 May 2023

Bridging the Gap between Academia and Industry: The Power of Collaboration in Life Sciences

In this behind-the-scenes interview, we speak to Dr. Sinead Knight, chair of SLAS Europe 2023, about this years programme, highlighting the key topics and speakers.

From Society for Laboratory Automation and Screening (SLAS) 25 May 2023

Women with menstrual cycle dysfunction may experience adverse cardiovascular health consequences

A study of more than 58,000 women over a 12-year period found that longer or shorter menstrual cycles were associated with a higher risk of developing cardiovascular disease, heart attack or atrial fibrillation (AFib), according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

24 May 2023

Therapy News and Research

Treatment with luspatercept improves red blood cell counts in patients with myelodysplastic syndromes

Addressing sexual health issues of breast cancer patients on endocrine therapy

Recent evolution of the LAAO therapy for thromboembolic complications

Fibromyalgia causes structural brain changes

The potential clinical benefit of the Multabody platform as a therapeutic for SARS-CoV-2

Nonhuman primate study helps explain how stem cell transplantation can kill HIV virus

UTHealth Houston receives federal funding for traumatic brain injury research

Case study: Experimental lecanemab treatment causes adverse outcomes in 65-year-old woman with Alzheimer's disease

Manipulating a signaling protein to slow down muscular dystrophy

A trans teen no longer feels welcome in Florida. So she left.

Bridging the Gap between Academia and Industry: The Power of Collaboration in Life Sciences

Women with menstrual cycle dysfunction may experience adverse cardiovascular health consequences

Mays Cancer Center conducts clinical trial combining two drugs in patients with recurrent, high-grade glioblastoma

Domestic violence shelters move out of hiding

What is the efficacy, safety, and tolerability of novel danuglipron in adults with type two diabetes?

Looking at cancer drugs to help put the brakes on classic indicators of aging

The antimicrobial potential of nanoparticles

Transcatheter edge-to-edge procedure to repair leaky mitral valves found to be safe and effective

Magnetic stimulation treats depression by reversing the direction of abnormal brain signals

Study provides data to support gene supplementation as a treatment for autosomal dominant retinitis pigmentosa

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News